These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 1702159

  • 1. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    Kowalski M, Bergeron L, Dorfman T, Haseltine W, Sodroski J.
    J Virol; 1991 Jan; 65(1):281-91. PubMed ID: 1702159
    [Abstract] [Full Text] [Related]

  • 2. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    Stevenson M, Haggerty S, Lamonica C, Mann AM, Meier C, Wasiak A.
    J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in the cytopathic effects of human immunodeficiency virus type 1 associated with a single amino acid alteration in the ectodomain of the gp41 transmembrane glycoprotein.
    Cao J, Vasir B, Sodroski JG.
    J Virol; 1994 Jul; 68(7):4662-8. PubMed ID: 8207841
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.
    Cao J, Park IW, Cooper A, Sodroski J.
    J Virol; 1996 Mar; 70(3):1340-54. PubMed ID: 8627650
    [Abstract] [Full Text] [Related]

  • 7. A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells.
    Elson HF, Dimitrov DS, Blumenthal R.
    Mol Membr Biol; 1994 Mar; 11(3):165-9. PubMed ID: 7742881
    [Abstract] [Full Text] [Related]

  • 8. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
    Gabuzda DH, Lever A, Terwilliger E, Sodroski J.
    J Virol; 1992 Jun; 66(6):3306-15. PubMed ID: 1583717
    [Abstract] [Full Text] [Related]

  • 9. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion.
    Helseth E, Olshevsky U, Gabuzda D, Ardman B, Haseltine W, Sodroski J.
    J Virol; 1990 Dec; 64(12):6314-8. PubMed ID: 2243396
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Freed EO, Myers DJ, Risser R.
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4650-4. PubMed ID: 2191297
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    Grimaila RJ, Fuller BA, Rennert PD, Nelson MB, Hammarskjöld ML, Potts B, Murray M, Putney SD, Gray G.
    J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
    [Abstract] [Full Text] [Related]

  • 12. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
    Freed EO, Delwart EL, Buchschacher GL, Panganiban AT.
    Proc Natl Acad Sci U S A; 1992 Jan 01; 89(1):70-4. PubMed ID: 1729720
    [Abstract] [Full Text] [Related]

  • 13. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
    Kiernan RE, Ono A, Englund G, Freed EO.
    J Virol; 1998 May 01; 72(5):4116-26. PubMed ID: 9557701
    [Abstract] [Full Text] [Related]

  • 14. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    Thali M, Furman C, Helseth E, Repke H, Sodroski J.
    J Virol; 1992 Sep 01; 66(9):5516-24. PubMed ID: 1501286
    [Abstract] [Full Text] [Related]

  • 15. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL, Theodore TS, Martin MA.
    J Virol; 1994 Jul 01; 68(7):4409-19. PubMed ID: 7515973
    [Abstract] [Full Text] [Related]

  • 16. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.
    Bergeron L, Sullivan N, Sodroski J.
    J Virol; 1992 Apr 01; 66(4):2389-97. PubMed ID: 1548769
    [Abstract] [Full Text] [Related]

  • 17. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity.
    Dubay JW, Roberts SJ, Brody B, Hunter E.
    J Virol; 1992 Aug 01; 66(8):4748-56. PubMed ID: 1629954
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y, Nakaya T, Fujinaga K, Kishi M, Azuma I, Ikuta K.
    J Gen Virol; 1994 Sep 01; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [Abstract] [Full Text] [Related]

  • 20. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Hart TK, Kirsh R, Ellens H, Sweet RW, Lambert DM, Petteway SR, Leary J, Bugelski PJ.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2189-93. PubMed ID: 2006155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.